MeSH Browser

MeSH Heading: Eicosapentaenoic Acid
Tree Number(s): D10.212.302.380.410.385; D10.251.355.255.200; D10.251.355.337.290; D10.627.430.450.390
Unique ID: D015118
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D015118
Scope Note: Important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families.
Entry Term(s): 5,8,11,14,17-Eicosapentaenoic Acid; 5,8,11,14,17-Icosapentaenoic Acid; Eicosapentanoic Acid; Icosapent; Timnodonic Acid; omega-3-Eicosapentaenoic Acid
Related Numbers: 1553-41-9
CAS Type 1 Name: 5,8,11,14,17-Eicosapentaenoic acid
Previous Indexing: Fatty Acids (1966-1972); Fatty Acids, Unsaturated (1973-1985)
Public MeSH Note: 1986; see 5,8,11,14,17-EICOSAPENTAENOIC ACID 1986-2003; EICOSAPENTANOIC ACID was indexed under FATTY ACIDS, UNSATURATED 2002-2010
History Note: 2003(1986);
Date Established: 1986/01/01
Date of Entry: 1985/06/05
Revision Date: 2020/06/22

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

biosynthesis (BI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

genetics (GE)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

physiology (PH)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M0023259
Related Numbers: 1553-41-9
Scope Note: Important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families.
Terms: Eicosapentaenoic Acid Preferred Term
Term UI T529577
Date01/02/2003
LexicalTag NON
ThesaurusID; Icosapent
Term UI T001005516
Date01/15/2020
LexicalTag NON
ThesaurusID; 5,8,11,14,17-Eicosapentaenoic Acid
Term UI T044164
Date01/01/1999
LexicalTag NON
ThesaurusID NLM (1986); 5,8,11,14,17-Icosapentaenoic Acid
Term UI T044167
Date06/05/1985
LexicalTag NON
ThesaurusID UNK (19XX); omega-3-Eicosapentaenoic Acid
Term UI T044165
Date06/05/1985
LexicalTag NON
ThesaurusID UNK (19XX); Timnodonic Acid
Term UI T044166
Date06/05/1985
LexicalTag NON
ThesaurusID UNK (19XX); Eicosapentanoic Acid
Term UI T772514
Date06/10/2010
LexicalTag NON
ThesaurusID NLM (2011)

Eicosapentaenoic Acid MeSH Descriptor Data 2024